Physician profile
John J Martinez
NPI 1891862785
$2,342.05
in general payments reported to CMS, 2019-2025
15 companies · $259 in 2025
The $259 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $264 · 2021: $185 · 2022: $120 · 2023: $370 · 2024: $712 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,341.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $769.55 | 2022-2025 | Sotyktu |
| Pfizer INC. | $451.17 | 2019-2021 | |
| Amgen INC. | $313.25 | 2021-2024 | Otezla |
| Abbvie INC. | $219.24 | 2024-2025 | |
| Ucb, INC. | $175.81 | 2020-2022 | |
| Celgene Corporation | $160.98 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $56.89 | 2019-2023 | Targretin, Siliq |
| Genzyme Corporation | $38.18 | 2022 | |
| Galderma Laboratories, L.P. | $24.90 | 2020 | |
| Journey Medical Corporation | $24.82 | 2024 | |
| Botanix Sb INC | $24.53 | 2025 | Sofdra |
| Sanofi-Aventis U.S. LLC | $23.80 | 2021 | |
| Smith+Nephew, INC. | $22.49 | 2023 | Renasys Go V2 Home |
| Integra Lifesciences Corporation | $19.62 | 2019 | |
| Organogenesis INC. | $16.82 | 2025 | Cygnus Dual |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.